Isomaltulose alleviates acute colitis via modulating gut microbiota and the Treg/Th17 balance in mice
- 14 July 2022
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 13 (16) , 8572-8584
Abstract
Isomaltulose was found to be a promising therapeutic agent for the prevention and adjunctive treatment of UC by maintaining intestinal immune homeostasis and remodelling the gut microbiota.Keywords
Funding Information
- Natural Science Foundation of Shandong Province (ZR2019BD027)
- National Natural Science Foundation of China (31900031)
This publication has 45 references indexed in Scilit:
- The gut-adherent microbiota of PSC–IBD is distinct to that of IBDGut, 2016
- Role of the normal gut microbiotaWorld Journal of Gastroenterology, 2015
- Intestinal Epithelium in Inflammatory Bowel DiseaseFrontiers in Medicine, 2014
- The IL-23–IL-17 immune axis: from mechanisms to therapeutic testingNature Reviews Immunology, 2014
- Current studies on sucrose isomerase and biological isomaltulose production using sucrose isomeraseApplied Microbiology and Biotechnology, 2014
- Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesityProceedings of the National Academy of Sciences of the United States of America, 2013
- Unravelling the pathogenesis of inflammatory bowel diseaseNature, 2007
- Interleukin-2 Signaling via STAT5 Constrains T Helper 17 Cell GenerationImmunity, 2007
- Effects of a palatinose-based liquid diet (Inslow) on glycemic control and the second-meal effect in healthy menMetabolism, 2007
- Transforming growth factor induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitisGut, 2006